Multi-omics peripheral and core regions of cancer.
- Published in:
- NPJ Systems Biology & Applications, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41540-022-00258-1
- By:
- Publication type:
- Article
Works by Dong, Xianan
Results: 7
1
2
Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice.
- Published in:
- Behavioral & Brain Functions, 2023, v. 19, n. 1, p. 1, doi. 10.1186/s12993-023-00209-8
- By:
- Publication type:
- Article
3
SOCE-mediated NFAT1–NOX2–NLRP1 inflammasome involves in lipopolysaccharide-induced neuronal damage and Aβ generation.
- Published in:
- Molecular Neurobiology, 2022, v. 59, n. 5, p. 3183, doi. 10.1007/s12035-021-02717-y
- By:
- Publication type:
- Article
4
Ginsenoside Rg1 ameliorates aging-induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice.
- Published in:
- Molecular Medicine Reports, 2021, v. 24, n. 5, p. N.PAG, doi. 10.3892/mmr.2021.12441
- By:
- Publication type:
- Article
5
Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR-mediated autophagy.
- Published in:
- Molecular Medicine Reports, 2021, v. 23, n. 6, p. N.PAG, doi. 10.3892/mmr.2021.12076
- By:
- Publication type:
- Article
6
peripheral and core regions of virus-host network of COVID-19.
- Published in:
- Briefings in Bioinformatics, 2021, v. 22, n. 6, p. 1, doi. 10.1093/bib/bbab169
- By:
- Publication type:
- Article
7
Ginsenoside Rg1 alleviates lipopolysaccharide-induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells.
- Published in:
- Experimental & Therapeutic Medicine, 2021, v. 22, n. 1, p. N.PAG, doi. 10.3892/etm.2021.10214
- By:
- Publication type:
- Article